1,5-DIPHENYL-3-BENZYLAMINO-1,5-DIHYDROPYRROLIDIN 2-ONES AS CB1 RECEPTOR MODULATORS

Compounds and pharmaceutical compositions comprising compounds of the Formula as CB1 receptor inverse agonists useful for reducing body weight in mammals, treating cognitive impairment associated with schizophrenia, and mitigating treatment emergent weight gain observed during treatment with antipsy...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SCHAUS, JOHN MEHNERT, KRUSHINSKI, JOSEPH HERMAN JUNIOR, TUPPER, DAVID EDWARD, KEDING, STACY JO, HU, JINGDAN, COFFEY, DAVID SCOTT
Format: Patent
Sprache:eng ; pol
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SCHAUS, JOHN MEHNERT
KRUSHINSKI, JOSEPH HERMAN JUNIOR
TUPPER, DAVID EDWARD
KEDING, STACY JO
HU, JINGDAN
COFFEY, DAVID SCOTT
description Compounds and pharmaceutical compositions comprising compounds of the Formula as CB1 receptor inverse agonists useful for reducing body weight in mammals, treating cognitive impairment associated with schizophrenia, and mitigating treatment emergent weight gain observed during treatment with antipsychotics.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_PL2094684TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PL2094684TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_PL2094684TT33</originalsourceid><addsrcrecordid>eNrjZAgy1DHVdfEM8HD1i_TRNdZ1cvWLivRx9PX089eFSHlEugT5B0QGBfn7eLp4-ikY6fr7uQYrOAYrODsZKgS5OrsGhPgHKfj6u4T6OAJZwTwMrGmJOcWpvFCam0HRzTXE2UM3tSA_PrW4IDE5NS-1JD7Ax8jA0sTMwiQkxNiYGDUAkw4vrQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>1,5-DIPHENYL-3-BENZYLAMINO-1,5-DIHYDROPYRROLIDIN 2-ONES AS CB1 RECEPTOR MODULATORS</title><source>esp@cenet</source><creator>SCHAUS, JOHN MEHNERT ; KRUSHINSKI, JOSEPH HERMAN JUNIOR ; TUPPER, DAVID EDWARD ; KEDING, STACY JO ; HU, JINGDAN ; COFFEY, DAVID SCOTT</creator><creatorcontrib>SCHAUS, JOHN MEHNERT ; KRUSHINSKI, JOSEPH HERMAN JUNIOR ; TUPPER, DAVID EDWARD ; KEDING, STACY JO ; HU, JINGDAN ; COFFEY, DAVID SCOTT</creatorcontrib><description>Compounds and pharmaceutical compositions comprising compounds of the Formula as CB1 receptor inverse agonists useful for reducing body weight in mammals, treating cognitive impairment associated with schizophrenia, and mitigating treatment emergent weight gain observed during treatment with antipsychotics.</description><language>eng ; pol</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20110531&amp;DB=EPODOC&amp;CC=PL&amp;NR=2094684T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20110531&amp;DB=EPODOC&amp;CC=PL&amp;NR=2094684T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SCHAUS, JOHN MEHNERT</creatorcontrib><creatorcontrib>KRUSHINSKI, JOSEPH HERMAN JUNIOR</creatorcontrib><creatorcontrib>TUPPER, DAVID EDWARD</creatorcontrib><creatorcontrib>KEDING, STACY JO</creatorcontrib><creatorcontrib>HU, JINGDAN</creatorcontrib><creatorcontrib>COFFEY, DAVID SCOTT</creatorcontrib><title>1,5-DIPHENYL-3-BENZYLAMINO-1,5-DIHYDROPYRROLIDIN 2-ONES AS CB1 RECEPTOR MODULATORS</title><description>Compounds and pharmaceutical compositions comprising compounds of the Formula as CB1 receptor inverse agonists useful for reducing body weight in mammals, treating cognitive impairment associated with schizophrenia, and mitigating treatment emergent weight gain observed during treatment with antipsychotics.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZAgy1DHVdfEM8HD1i_TRNdZ1cvWLivRx9PX089eFSHlEugT5B0QGBfn7eLp4-ikY6fr7uQYrOAYrODsZKgS5OrsGhPgHKfj6u4T6OAJZwTwMrGmJOcWpvFCam0HRzTXE2UM3tSA_PrW4IDE5NS-1JD7Ax8jA0sTMwiQkxNiYGDUAkw4vrQ</recordid><startdate>20110531</startdate><enddate>20110531</enddate><creator>SCHAUS, JOHN MEHNERT</creator><creator>KRUSHINSKI, JOSEPH HERMAN JUNIOR</creator><creator>TUPPER, DAVID EDWARD</creator><creator>KEDING, STACY JO</creator><creator>HU, JINGDAN</creator><creator>COFFEY, DAVID SCOTT</creator><scope>EVB</scope></search><sort><creationdate>20110531</creationdate><title>1,5-DIPHENYL-3-BENZYLAMINO-1,5-DIHYDROPYRROLIDIN 2-ONES AS CB1 RECEPTOR MODULATORS</title><author>SCHAUS, JOHN MEHNERT ; KRUSHINSKI, JOSEPH HERMAN JUNIOR ; TUPPER, DAVID EDWARD ; KEDING, STACY JO ; HU, JINGDAN ; COFFEY, DAVID SCOTT</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_PL2094684TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; pol</language><creationdate>2011</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SCHAUS, JOHN MEHNERT</creatorcontrib><creatorcontrib>KRUSHINSKI, JOSEPH HERMAN JUNIOR</creatorcontrib><creatorcontrib>TUPPER, DAVID EDWARD</creatorcontrib><creatorcontrib>KEDING, STACY JO</creatorcontrib><creatorcontrib>HU, JINGDAN</creatorcontrib><creatorcontrib>COFFEY, DAVID SCOTT</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SCHAUS, JOHN MEHNERT</au><au>KRUSHINSKI, JOSEPH HERMAN JUNIOR</au><au>TUPPER, DAVID EDWARD</au><au>KEDING, STACY JO</au><au>HU, JINGDAN</au><au>COFFEY, DAVID SCOTT</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>1,5-DIPHENYL-3-BENZYLAMINO-1,5-DIHYDROPYRROLIDIN 2-ONES AS CB1 RECEPTOR MODULATORS</title><date>2011-05-31</date><risdate>2011</risdate><abstract>Compounds and pharmaceutical compositions comprising compounds of the Formula as CB1 receptor inverse agonists useful for reducing body weight in mammals, treating cognitive impairment associated with schizophrenia, and mitigating treatment emergent weight gain observed during treatment with antipsychotics.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; pol
recordid cdi_epo_espacenet_PL2094684TT3
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title 1,5-DIPHENYL-3-BENZYLAMINO-1,5-DIHYDROPYRROLIDIN 2-ONES AS CB1 RECEPTOR MODULATORS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T09%3A22%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SCHAUS,%20JOHN%20MEHNERT&rft.date=2011-05-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EPL2094684TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true